EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ketamine effects on EEG and their links to therapy differ across treatment-resistant major depression, post-traumatic stress disorder, and obsessive-compulsive disorder

Shabah M Shadli iD, Neda Nasrollahi iD, Calvin K Young iD, Gabrielle S R Schuck iD, Meadow G Whatson, Tame N J Kawe iD, Shona Neehoff, Ben Beaglehole iD, Paul Glue iD, Neil McNaughton iD

International Journal of Neuropsychopharmacology · 01.07.2026 · 29 (7)

DOI: 10.1093/ijnp/pyag037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, online erschienen am 06.07.2026. Verfasst von Shabah M Shadli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Ketamine, Obsessive-Compulsive Disorder, Stress Disorders, Post-Traumatic, Major Depressive Disorder. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Council New Zealand project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Neurotic disorders—major depressive disorder (MDD), panic disorder, social anxiety disorder, generalized anxiety disorder, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and specific phobia—have differing pharmaceutical profiles. But all, even when resistant to conventional treatment (TR), respond quickly to low-dose (0.5-1.0 mg/kg I.M.) ketamine. We explore the variation in the neural effects of ketamine across its treatments of TR-MDD, TR-PTSD, and TR-OCD. Materials and methods We recorded 10 min of resting frontal activity and diagnosis-related scale measures, before and 2 h after fentanyl (50 mcg) or ketamine (0.5 or 1.0 mg/kg, I.M.) counterbalanced across 3 sessions at least a week apart. Average power spectra were calculated for delta, theta, alpha1, alpha2, beta, and gamma bands. Analysis of variance compared TR-PTSD (20 F, 2 M) with TR-MDD (12 F, 13 M). Preliminary TR-OCD (5 F, 2 M) data were also obtained.

Results

TR-PTSD patients showed dose- and band frequency-dependent electroencephalography (EEG) power changes (particularly alpha at 0.05 mg/kg), while TR-MDD patients did not. TR-OCD differed qualitatively from both. The correlation of power change with score change was maximal for different bands and electrodes across the different scales (Impact of Events Scale-Revised, Montgomery-Åsberg Depression Rating Scale, Hospital Anxiety and Depression Scales, Hamilton Anxiety Scale, Fear Questionnaire, and Yale-Brown Obsessive-Compulsive Scale).

Discussion

Ketamine effects and their therapeutic links vary in band and site with conventional diagnosis—including previous TR anxiety results. The EEG results appear to detect changes in the disorder-specific systems that conventional treatments target selectively and directly and these appear to require a ketamine-sensitive factor (as a “double hit”) to generate disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineObsessive-Compulsive DisorderStress Disorders, Post-TraumaticMajor Depressive DisorderDepressive Disorder, Treatment-ResistantBrain WavesHumansMaleElectroencephalographyFemaleAdultMiddle AgedTreatment Effect HeterogeneityDose-Response Relationship, Drug

Stichwörter der Autor:innen

EEGdepressionketamineobsessive-compulsive disorderpost-traumatic stress disorder

Substanzen

Ketamine

Autor:innen und Institutionen

  • Department of Psychology, University of Otago, Dunedin, New Zealand.
  • Department of Psychology, Charles Sturt University, Bathurst, NSW, Australia.
  • Department of Psychological Medicine, University of Otago, Christchurch, New Zealand.

ORCID-Profile: Shabah M Shadli, Neda Nasrollahi, Calvin K Young, Gabrielle S R Schuck, Tame N J Kawe, Ben Beaglehole, Paul Glue, Neil McNaughton

Förderung

  • Health Research Council New Zealand project

Zitieren

APA

Shadli, S. M., Nasrollahi, N., Young, C. K., Schuck, G. S. R., Whatson, M. G., Kawe, T. N. J., Neehoff, S., Beaglehole, B., Glue, P., & McNaughton, N. (2026). Ketamine effects on EEG and their links to therapy differ across treatment-resistant major depression, post-traumatic stress disorder, and obsessive-compulsive disorder. International Journal of Neuropsychopharmacology, 29(7). https://doi.org/10.1093/ijnp/pyag037

Vancouver

Shadli SM, Nasrollahi N, Young CK, Schuck GSR, Whatson MG, Kawe TNJ, et al. Ketamine effects on EEG and their links to therapy differ across treatment-resistant major depression, post-traumatic stress disorder, and obsessive-compulsive disorder. International Journal of Neuropsychopharmacology. 2026;29(7). doi:10.1093/ijnp/pyag037

BibTeX
@article{Shadli2026,
  author = {Shadli, Shabah M and Nasrollahi, Neda and Young, Calvin K and Schuck, Gabrielle S R and Whatson, Meadow G and Kawe, Tame N J and Neehoff, Shona and Beaglehole, Ben and Glue, Paul and McNaughton, Neil},
  title = {Ketamine effects on EEG and their links to therapy differ across treatment-resistant major depression, post-traumatic stress disorder, and obsessive-compulsive disorder},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2026},
  volume = {29},
  number = {7},
  doi = {10.1093/ijnp/pyag037}
}
Kostenlos starten →